Literature DB >> 1759822

Differential modulation of cytokine production by macrolides: interleukin-6 production is increased by spiramycin and erythromycin.

S Bailly1, J J Pocidalo, M Fay, M A Gougerot-Pocidalo.   

Abstract

Antibiotics do not act alone but act in conjunction with the host defense system. In particular, it has been shown that some antibiotics can modify cytokine production. We compared the in vitro effects of three macrolides (roxithromycin, spiramycin, and erythromycin) actively concentrated by leukocytes on interleukin-1 alpha, (IL-1 alpha), IL-1 beta, IL-6, and tumor necrosis factor alpha production by human monocytes stimulated with lipopolysaccharide. Our results show that the three macrolides tested have different effects on production of these cytokines. Spiramycin and, to a lesser extent, erythromycin increased total IL-6 production without affecting IL-1 alpha, IL-1 beta, or tumor necrosis factor alpha production, whereas roxithromycin had no effect. To our knowledge, this is the first time that an antibiotic has been shown to increase IL-6 production.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1759822      PMCID: PMC245317          DOI: 10.1128/AAC.35.10.2016

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  32 in total

1.  Comparison of the in-vitro effect of several macrolides on the oxidative burst of human neutrophils.

Authors:  M T Labro; J el Benna; C Babin-Chevaye
Journal:  J Antimicrob Chemother       Date:  1989-10       Impact factor: 5.790

Review 2.  Interleukin 1, interleukin 6 and tumor necrosis factor in infection, inflammation and immunity.

Authors:  K Bendtzen
Journal:  Immunol Lett       Date:  1988-11       Impact factor: 3.685

3.  Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression.

Authors:  D H Perlmutter; C A Dinarello; P I Punsal; H R Colten
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

4.  Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.

Authors:  J Gauldie; C Richards; D Harnish; P Lansdorp; H Baumann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

Review 5.  Interleukin-1 and its biologically related cytokines.

Authors:  C A Dinarello
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

6.  Detection of human IL-1 alpha and IL-1 beta at the subpicomolar level by colorimetric sandwich enzyme immunoassay.

Authors:  B Ferrua; P Becker; L Schaffar; A Shaw; M Fehlmann
Journal:  J Immunol Methods       Date:  1988-11-10       Impact factor: 2.303

7.  Modulation of the proliferative response of murine thymocytes stimulated by IL-1, and enhancement of IL-1 beta secretion from mononuclear phagocytes by tetracyclines.

Authors:  E Ingham
Journal:  J Antimicrob Chemother       Date:  1990-07       Impact factor: 5.790

8.  Multiple forms of IFN-beta 2/IL-6 in serum and body fluids during acute bacterial infection.

Authors:  D C Helfgott; S B Tatter; U Santhanam; R H Clarick; N Bhardwaj; L T May; P B Sehgal
Journal:  J Immunol       Date:  1989-02-01       Impact factor: 5.422

Review 9.  The biology of cachectin/TNF--a primary mediator of the host response.

Authors:  B Beutler; A Cerami
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

10.  Cellular uptake and subcellular distribution of roxithromycin and erythromycin in phagocytic cells.

Authors:  M B Carlier; A Zenebergh; P M Tulkens
Journal:  J Antimicrob Chemother       Date:  1987-11       Impact factor: 5.790

View more
  12 in total

1.  Differential modulatory effects of clarithromycin on the production of cytokines by a tumor.

Authors:  K Sassa; Y Mizushima; M Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

2.  Efficacy of erythromycin lactobionate for treating Pseudomonas aeruginosa bacteremia in mice.

Authors:  Y Hirakata; M Kaku; K Tomono; K Tateda; N Furuya; T Matsumoto; R Araki; K Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

3.  Therapeutic effect of clarithromycin on a transplanted tumor in rats.

Authors:  K Sassa; Y Mizushima; T Fujishita; R Oosaki; M Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

Review 4.  Immunomodulating effects of antibiotics: literature review.

Authors:  B Van Vlem; R Vanholder; P De Paepe; D Vogelaers; S Ringoir
Journal:  Infection       Date:  1996 Jul-Aug       Impact factor: 3.553

5.  Cytokine mRNA expression in lesions in cats with chronic gingivostomatitis.

Authors:  R Harley; C R Helps; D A Harbour; T J Gruffydd-Jones; M J Day
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

6.  Clindamycin modulates inflammatory-cytokine induction in lipopolysaccharide-stimulated mouse peritoneal macrophages.

Authors:  Tetsuji Nakano; Kazufumi Hiramatsu; Kenji Kishi; Norio Hirata; Jun-Ichi Kadota; Masaru Nasu
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

7.  Reduction by cefodizime of the pulmonary inflammatory response induced by heat-killed Streptococcus pneumoniae in mice.

Authors:  Y Bergeron; N Ouellet; A M Deslauriers; M Simard; M Olivier; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

8.  Potential effects of erythromycin on host defense systems and virulence of Pseudomonas aeruginosa.

Authors:  Y Hirakata; M Kaku; R Mizukane; K Ishida; N Furuya; T Matsumoto; K Tateda; K Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

9.  Erythromycin inhibits tumor necrosis factor alpha and interleukin 6 production induced by heat-killed Streptococcus pneumoniae in whole blood.

Authors:  M J Schultz; P Speelman; S Zaat; S J van Deventer; T van der Poll
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

Review 10.  Roxithromycin. An update of its antimicrobial activity, pharmacokinetic properties and therapeutic use.

Authors:  A Markham; D Faulds
Journal:  Drugs       Date:  1994-08       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.